CIP-Isotretinoin

isotretinoin · Cipher Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CIP-Isotretinoin, covering 2014-07-04 to 2014-07-04. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne [Phase 3]